Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial
Nutrients · 19.11.2026 · 18 (22) · 3859
DOI: 10.3390/nu18223859 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 19.11.2026. Verfasst von Li Wang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Medical Innovation Research Project of Shanghai Municipal Science and Technology Commission.
Abstract (Originalsprache)
Objective
Acute kidney injury (AKI) is a frequent and serious complication in infants after cardiac surgery. Glutamine (GLN), a conditionally essential amino acid, has demonstrated renoprotective potential in animal models and has been shown to attenuate biomarkers of kidney damage in high-risk patients undergoing cardiac surgery. However, whether these renoprotective benefits extend to pediatric patients remains unknown.
Methods
We conducted a single-center, randomized, double-blind, placebo-controlled trial in infants and young children younger than 3 years undergoing cardiac surgery with cardiopulmonary bypass. Ninety-four patients were randomly assigned to receive intravenous alanyl-glutamine (0.4 g/kg/day, n = 47) or 0.9% saline placebo (n = 47), administered from anesthesia induction and continued for 4 consecutive days (the day of surgery and the first 3 postoperative days). The primary outcome was the incidence of AKI within 72 h postoperatively, defined according to the KDIGO criteria. Secondary outcomes included the requirement for peritoneal dialysis (PD), diuretic use, serum creatinine (Scr), neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, procalcitonin, and the lengths of ICU and hospital stay.
Results
The incidence of KDIGO-defined AKI was lower in the GLN group than in the control group (14.9% vs. 40.4%; p = 0.010). Among the prespecified secondary outcomes, the requirement for PD (0% vs. 12.8%; p = 0.026) and diuretic use (6.4% vs. 23.4%; p = 0.040) were also lower in the GLN group. Postoperative NGAL concentrations were lower in the GLN group at 24, 48, and 72 h (p < 0.050 for each time point). No significant differences were observed in the lengths of ICU or hospital stay.
Conclusions
In this single-center trial, perioperative GLN supplementation was associated with a lower incidence of postoperative AKI, a lower requirement for PD, and less diuretic use in infants undergoing elective cardiac surgery. These exploratory findings support a possible renoprotective role for GLN in this high-risk population but require confirmation in larger multicenter trials before adoption into clinical practice.
Förderung
- National Natural Science Foundation of China
- Medical Innovation Research Project of Shanghai Municipal Science and Technology Commission
Zitieren
APA
Wang, L., Qin, W., Li, J., Hong, H., & Li, X. (2026). Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial. Nutrients, 18(22), 3859. https://doi.org/10.3390/nu18223859
Vancouver
Wang L, Qin W, Li J, Hong H, Li X. Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial. Nutrients. 2026;18(22):3859. doi:10.3390/nu18223859
BibTeX
@article{Wang2026,
author = {Wang, Li and Qin, Wenjun and Li, Jia and Hong, Haifa and Li, Xiaobing},
title = {Effect of Perioperative Glutamine Supplementation on Acute Kidney Injury in Infants Undergoing Elective Cardiac Surgery: A Randomized Controlled Trial},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {22},
pages = {3859},
doi = {10.3390/nu18223859}
}
EUVIMED